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Abstract: Aim: We examined the reduced blood pressure (BP) nocturnal fall in patients with
obstructive sleep apnea (OSA) by a meta-analysis including studies that provided data on prevalence
rates of non-dipping (ND) pattern during 24-h ambulatory blood pressure monitoring (ABPM). Design:
The PubMed, OVID-MEDLINE, and Cochrane CENTRAL literature databases were searched for
appropriate articles without temporal restriction up to April 2019 through focused and sensitive search
methods. Studies were identified by crossing the search terms as follows: “obstructive sleep apnea”,
“sleep quality”, “non dipping”, “reduced nocturnal BP fall”, “circadian BP variation”, “night-time
BP”, and “ambulatory blood pressure monitoring”. Results: Meta-analysis included 1562 patients
with OSA from different clinical settings and 957 non-OSA controls from 14 studies. ND pattern
prevalence in patients with OSA widely varied among studies (36.0–90.0%). This was also the case for
non-OSA controls (33.0% to 69.0%). Overall, the ND pattern, assessed as an event rate in the pooled
OSA population, was 59.1% (confidence interval (CI): 52.0–65.0%). Meta-analysis of the seven studies
comparing the prevalence of ND pattern in participants with OSA and controls showed that OSA
entails a significantly increased risk of ND (Odds ratio (OR) = 1.47, CI: 1.07–1.89, p < 0.01). After the
exclusion of patients with mild OSA, OR increased to 1.67 (CI: 1.21–2.28, p < 0.001). Conclusions:
The present meta-analysis, extending previous information on the relationship between OSA and
impaired BP dipping, based on single studies, suggests that this condition increases by approximately
1.5 times the likelihood of ND, which is a pattern associated with a greater cardiovascular risk than
normal BP dipping.
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1. Introduction
Ambulatory blood pressure monitoring (ABPM) provides the unique opportunity to assess
circadian blood pressure (BP) variability [1]. A large amount of evidence has demonstrated that
night-time systolic and diastolic BP values are 10–20% lower than corresponding day-time values
in the large majority of normotensive healthy subjects and uncomplicated hypertensive patients [2].
The nocturnal BP fall is closely linked to the physiological reduction of the sympathetic nervous
system during the night-time period, which results in a pronounced decrease in cardiac output, arterial
resistances, and heart rate [3].
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The extent of day/night BP variations in population-based samples and, in general, hypertensive
cohorts has been related to several factors such as age, ethnicity, intensity of diurnal physical activity,
job stress, smoking habits, quality of sleep, seasonal influence, and co-morbidities [4–6].
A reduced BP fall at night (the defined non-dipping, defined as a <10% BP reduction of night-time
vs. daytime BP or night-time/day-time BP ratio ≥0.90) has been reported to be highly frequent in
several morbid conditions, including obstructive sleep-apnea syndrome (OSA) [7–9].
OSA, which is often associated with hypertension, obesity, diabetes, and metabolic syndrome, is a
highly prevalent chronic condition in the general population, characterized by a marked stimulation of
the sympathetic activity induced by recurrent nocturnal desaturation episodes [10].
Since increased sympathetic activity has been proposed as one of the major mechanisms responsible
of alterations in BP and circadian BP rhythm (i.e., non-dipping and reverse pattern), numerous studies
have targeted the association of OSA with BP disorders [11,12]. Regarding the relationship of OSA
with the non-dipping (ND) pattern, available evidence is so far limited to relatively few investigations,
based on small-scale studies, conducted in different clinical settings and, more importantly, with
inconsistent conclusions [13].
Taking all these aspects into account, we, therefore, decided to make a systematic meta-analysis of
the studies that addressed this specific topic with the primary aim to expand available evidence in this
research field.
2. Materials and Methods
2.1. Search Strategy and Study Selection
The present study was carried-out following the Preferred Reporting Items for Systematic reviews
and Meta-Analyses (PRISMA) guidelines [14]. Pertinent literature was examined to detect all papers
providing findings on the association of OSA with the ND pattern, as assessed by ABPM.
The PubMed, OVID-MEDLINE, and Cochrane CENTRAL databases were systematically analyzed
for English-language research articles without time restriction until April 2019.
Studies were detected by using the following terms: “obstructive sleep apnea”, “sleep quality”,
“non dipping”, “reduced nocturnal BP fall”, “reverse dipping”, “circadian BP variation”, “night-time
BP”, and “ambulatory blood pressure monitoring”. Checks of the reference lists of selected papers
integrated the electronic search. Reviews, editorials, case reports, and letters were excluded from
analyses, but were examined for potential additional references. Two authors (CC and EG) assessed
retrieved abstracts and full text of these studies to establish eligibility, according to the inclusion criteria
mentioned below. A third reviewer (CS) resolved disagreements on study judgments. Data extraction
were performed by one reviewer (CC) and independently checked by another reviewer (CS).
Inclusion criteria were: (1) English articles published in peer-reviewed journals, (2) studies
providing information on the prevalence of the ND pattern in OSA individuals, and (3) minimum set
of data including age, gender, Body surface area (BSA), or body mass index (BMI). Specific exclusion
criteria were: (1) studies with less than 10 patients with OSA, and (2) studies conducted in children
and adolescents (age <18 years).
The first literature screening identified a total of 159 papers. After the initial search of titles and
abstracts, 659 papers were excluded and 90 were reviewed. Of these, 14 studies [15–28] fulfilled the
inclusion criteria and comprised sufficient data to be enclosed in the present review (Figure 1).
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Figure 1. Schematic flow-chart for the selection of studies. 
2.2. Definitions 
Ambulatory blood pressure measurements and definition of the non-dipping status. 
ABPM was performed by using validated devices in all studies. Spacelabs 90207 (Spacelabs, 
Redmond, WA, USA) was the most frequently employed monitoring equipment (7 studies), which is 
followed by FM 800 or FB 250 (Fukuda, Denshy Ltd., Tokio, Japan) (3 studies). Instruments were set 
to take BP readings at different time intervals (day-time:15–30 min and night-time: 20–60 min) 
(Supplementary Table S1). 
Patients were defined as non-dippers (data provided by 12 out of 14 studies) when mean 
night-time BP (5 studies), systolic/diastolic BP (4 studies), and systolic BP (3 studies) decreased by 
≤10% compared to day-time values. 
The night-time period was defined according to five different criteria (data from 13 studies). 
Day–time and night-time periods were classified according to an individual’s diary in six studies 
[19,23,24,26–28]. Fixed time intervals were used to define the night-time period in the remaining 
studies: 10.00 PM–6.00 AM (four studies) [15,17,21,25], 10.00 PM–7.00 AM [18], 11.00 PM–6.00 AM 
[20], and 12.00 PM–6.00 AM [16]. 
2.3. Obstructive Sleep Apnea Syndrome Definition 
In the selected studies, respiratory events were scored according to the recommendations of 
major guidelines as follows: an apneic event was defined as ≥90% decrease in airflow from the 
baseline value for ≥10 s. Hypopnea was variously classified as a 30%–50% decrease in airflow lasting 
at least 10 s that may or may not be associated with arousals or 3%–4% oxy-hemoglobin 
desaturation. OSA was defined according to the apnea/hypo-apnea index (AHI) cut-off of ≥15 
events/h in eight studies, ≥5 events/h in six studies, and ≥30 events/h in one study. Diagnosis of OSA 
was made out-of-hospital by unattended home sleep recordings via polysomnography in four 
studies [15,20,26,28] and by polygraphy in three studies [21,24,27], respectively, and in the hospital 
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2.2. Definitions
Ambulatory blood pressure measurements and definition of the non-dipping status.
ABPM was performed by using validated devices in all studies. Spacelabs 90207 (Spacelabs,
Redmond, WA, USA) was the most frequently employed monitoring equipment (7 studies), which
is followed by FM 800 or FB 250 (Fukuda, Denshy Ltd., Tokio, Japan) (3 studies). Instruments were
set to take BP readings at different time intervals (day-time:15–30 min and night-time: 20–60 min)
(Supplementary Table S1).
Patients were defined as non-dippers (data provided by 12 out of 14 studies) when mean night-time
BP (5 studies), systolic/diastolic BP (4 studies), and systolic BP (3 studies) decreased by ≤10% compared
to day-time values.
The night-time period was defined according to five different criteria (data from 13 studies). Day–time
and night-time periods were classified according to an individual’s diary in six studies [19,23,24,26–28].
Fixed time intervals were used to define the night-time period in the remaining studies: 10.00 PM–6.00
AM (four studies) [15,17,21,25], 10.00 PM–7.00 AM [18], 11.00 PM–6.00 AM [20], and 12.00 PM–6.00
AM [16].
2.3. Obstructive Sleep Apnea Syndrome Definition
In the selected studies, respiratory events were scored according to the recommendations of major
guidelines as follows: an apneic event was defined as ≥90% decrease in airflow fro the baseline
value for ≥10 s. Hypopnea was variously classified as a 30–50% decrease in airflow lasting at least 10 s
that may or may not be associated with arousals or 3–4% oxy-hemoglobin desaturation. OSA was
defined according to the apnea/hypo-apnea index (AHI) cut-off of ≥15 events/h in eight studies, ≥5
events/h in six studies, and ≥30 events/h in one study. Diagnosis of OSA was made out-of-hospital
by unattended home sleep recordings via polysomnography in four studies [15,20,26,28] and by
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polygraphy in three studies [21,24,27], respectively, and in the hospital setting (sleep laboratory) in the
other seven studies [16–19,22,23,25] by using different commercial devices.
2.4. Statistical Analysis
The aim of the review was to assess the prevalence of ND pattern in the OSA setting, according to
the criteria provided by the studies. In order to calculate average ND pattern prevalence in the entire
population, we performed a meta-analysis of data provided by the 14 selected studies and considered
ND occurrence as an event rate.
Clinical features retrieved by selected studies are expressed as absolute numbers, mean± standard
deviation (SD), or inter-quartile range.
Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated in order to evaluate the
statistical difference of the ND pattern frequency between OSA and controls (data provided by seven
studies).
A pooled analysis of the previously mentioned variables was carried out using fixed or random
effects models by Comprehensive Meta-Analysis Version 2, Biostat, Englewood, NJ. The limit of
statistical significance was set at p < 0.05.
Heterogeneity was assessed by using I-square, Q, and tau-square values. The random effect
model was applied when heterogeneity across studies was high (I2 > 75). Relevant publication bias
was evaluated by using the funnel plot method, according to the trim and fill test. Among observed
and adjusted values, their lower and upper limits have been calculated.
3. Results
Overall, 2519 participants (1562 with OSA and 957 controls) were enrolled in 14 studies (sample
size ranged from 44 to 703), performed in three different geographical areas (Asia = 7, South America = 3,
North America = 2, Europe = 2). Notably, 1672 subjects (66.4%) were examined in Asia, 342 subjects
(13.5%) in North America, 329 subjects (13.1%) in South America, and 177 subjects (7.0%) in Europe.
Table 1 reports the main features of selected studies comprising year of publication, OSA sample
size, presence of controls, prevalence of men, mean age, body mass index (BMI), night-time BP, clinical
setting, and definition of OSA. Six out of 14 studies included untreated or treated hypertensive patients,
three studies included normotensive individuals from different settings (obese, elderly, and apparently
healthy subjects), and other studies investigated mixed normotensive/hypertensive samples, members
of the general population, patients with cardiovascular disease, or focused on severe OSA. Only seven
studies included non-OSA individuals as a control group.
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BP (mmHg) Setting OSA Definition
Loredo [15], 2001 44 No 35 48 32 - UncomplicatedNT and HTN AHI ≥ 15
Tsioufis [16], 2008 62 70 56 48 32 123/78 Uncomplicated,untreated HTN AHI ≥ 5
Sasaki [17], 2012 215 No 190 - - - NT, untreated/treated HT AHI ≥ 5
Onen [18], 2012 30 15 21 77 27 132/73 Elderly NT AHI ≥ 15
Ishikawa [19], 2012 69 52 61 55 27 - NT and HTN AHI ≥ 15
Lee [20], 2014 63 640 36 60 24 - Generalpopulation AHI ≥ 15
Seif [21], 2014 298 No 294 63 34 116/64 Cardiovasculardisease AHI ≥ 15
Sarinc Ulasli [22], 2014 62 No 43 52 32 115/73 Healthy NT AHI ≥ 5
Sasaki [23], 2014 251 No 227 60 26 123/79 Prevalent HTN AHI ≥ 5
Correa [24], 2017 26 55 12 44 34 115/70 Obese NT AHI ≥ 15
Ma [25], 2017 56 No 40 48 27 - Untreated HTN AHI ≥ 5
Jenner [26], 2017 52 43 28 59 32 124/72 Treated HTN AHI ≥ 15
Genta Pereira [27], 2018 77 76 33 64 30 129/70 Treated HTN AHI ≥ 15
Sesizuka [28], 2018 264 - 219 55 28 123/81 Severe OSA AHI ≥ 30
AHI = apnea/hypo-apnea index. BMI = body mass index. BP = blood pressure. HTN = hypertension. NT = normotension. OSA = obstructive sleep apnea. Data are presented as absolute
numbers, mean ± SD, or inter-quartile range.
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3.1. Clinical Characteristics of Patients with OSA
Average age range was 44 to 77 years [18,24] and 84% of participants were men. Mean BMI
varied from 24.0 ± 3.0 kg/m2 (20) to 34.0 ± 6.0 kg/m2 [21] (data provided by 13 studies). Average
night-time systolic BP ranged from 115 ± 8 mmHg [24] to 132 ± 16 mmHg [18] and diastolic BP from
70 ± 8 mmHg [24] to 81 ± 10 mmHg [28] (data from nine studies).
3.2. Prevalence of the ND Pattern
ND pattern prevalence in patients with OSA consistently varied among studies (36.0–90.0%).
Corresponding figures in non-OSA controls ranged from 33% to 69%. Figure 2 shows the Forest
plot of prevalence rates of the ND pattern in patients with OSA. The overall prevalence of this
nocturnal BP phenotype, assessed as an event rate, in the pooled population was 59.1% (CI: 52.0–65.0%).
An additional, separate analysis of studies that included only patients with mild OSA [16,17,22,23,25]
showed a significant lower prevalence of the ND pattern in this subset (46%, CI: 46–65%) as compared
to the whole pooled population.
The meta-analysis of the seven studies that provided data on the prevalence rates of the ND
pattern in patients with OSA and in their non-OSA counterparts suggested that the former group had
a significantly increased risk of a reduced fall in night-time BP (OR = 1.47, CI: 1.07–1.89, p < 0.01)
(Figure 3).
Figure 4 reports the findings of the meta-analysis of six studies that excluded patients with
AHI <15 events/hour (i.e., mild OSA). In this pooled population with a moderate to severe OSA, the
likelihood to have an ND pattern was 1.67 times higher (CI: 1.21–2.28, p < 0.001) than the controls.
A funnel plot ruled out the presence of significant publication bias of studies by assessing the
prevalence of the ND pattern in individuals with and without OSA (Figure 5). Lastly, the adjustment for
publication bias did not abolish the difference in the ND pattern prevalence between OSA and controls.
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4. Discussion
Our meta-analysis of 14 studies published in the last two decades adds a new piece of information
on the relationship between OSA and the ND pattern in a pooled population from different settings
totaling 2519 normotensive, untreated, and treated hypertensive individuals without and with mild
(i.e., AHI ≥ 5 events/hour, five studies), moderate to severe (i.e., AHI ≥ 15 events/hour, eight studies)
and severe (i.e., AHI ≥ 30 events/hour, one study) OSA.
We found that the prevalence rates of the ND pattern, as assessed by a single ABPM recording, in
patients with OSA and controls widely varied among the selected studies (36.0–90.0% and 33.0% to
69.0%, respectively). This depends on the differences in demographic/clinical characteristics, definitions
of OSA and ND phenotypes, as well as the modality of performing ABPM and polysomnography (i.e.,
home or hospital).
More importantly, we have been able to show that the ND pattern is present in most patients with
OSA, with a pooled prevalence of 59.0%. Further vital information from our meta-analysis concerns the
estimate of the magnitude of risk of reduced nocturnal BP dip associated with OSA. The probability of
having an ND pattern in patients with OSA was 46% higher and 67% higher than controls, depending
on whether subjects with mild OSA were included or excluded, respectively. These results suggest
that this risk is linked to the OSA severity. Lastly, prevalence rates of ND as well as ORs entailed by
OSA based on pooled data from the selected studies were un-affected by publication bias or a single
effect study.
Before further commenting on the main findings and limitations of our study, some general
aspects related to the prevalence of OSA and ND, as well as the mechanisms that determine alterations
in circadian BP rhythm in the OSA setting, deserve to be briefly discussed.
Recent epidemiological studies have shown a rapid growth in the prevalence of sleep disordered
breathing. Moderate to severe OSA, as defined by an apnea–hypopnea index (AHI) > 15, has
been recently reported in up to one half of men and a quarter of women belonging to the general
population [29]. At the same time, although obesity levels have risen dramatically, epidemic obesity
does not fully explain the increasing burden of OSA. This is because the measurement techniques and
diagnostic scoring criteria have also changed markedly over the same period. Cross sectional studies
have reported independent associations between severity of OSA and hypertension after adjusting for
confounders. Furthermore, a close relationship between OSA and BP disorders has been confirmed by
observational and interventional studies in which OSA was found to be a major predictor of incident
hypertension and an ND pattern [30].
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In the same period, the widespread use of ABPM has documented that a reduced or even absent
night-time BP occurs in a remarkable fraction of hypertensive cohorts (20–40%), independently from
several variables such as ethnicity, age, and gender [31]. It is also noted that, even at the community
level, the ND pattern is not rare. A pioneering contribution regarding ambulatory BP patterns in the
general population comes from the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA)
study, which is an observational survey carried out in 2051 Italian individuals, randomly selected from
the residents in Monza (Milan, Italy) [32]. In the PAMELA population, ND prevalence varied from
15% to 20% depending on whether this nocturnal BP pattern was identified by systolic or diastolic BP
nocturnal drop or both. Taken together, these data indicate that both OSA and non-dipping patterns
are frequent conditions in the community.
There is a general consensus that the physiological nocturnal BP drop is largely due to a decrease
in the sympathetic tone, which leads to a pronounced fall in both cardiac output and peripheral artery
resistances. A large amount of reports has shown that plasma norepinephrine and epinephrine levels
exhibit circadian variations with a nadir during night-time sleep [3].
Studies based on direct recording of muscle sympathetic nerve activity via microneurography
have suggested that day-night BP difference is inversely related to sympathetic nerve traffic (i.e., the
greater the sympathetic awake tone, the lesser the magnitude of nocturnal hypotension) [33]. There is
also evidence of a link between the non-dipping pattern to an altered renal capacity to excrete sodium
during the day. It has been shown that nocturnal BP throughout the pressure-natriuresis mechanism
may lead to an increased sodium excretion, which determines a preservation of the sodium balance [11].
As for the relation between OSA and abnormal nocturnal BP dipping (i.e., ND and reverse
dipping), the mechanisms by which this condition promote the presence of ND include recurrent
hypoxaemia and hypercapnia, cortical microarousals, raised oxidative stress, and fragmented sleep,
in which the synergistic effects lead to transient elevations of BP, likely via sympathetic activation.
Intermittent hypoxia has been considered one of the main factors involved in the development of
hypertension among patients with OSA [34]. In addition, emerging evidence suggests that sleep
fragmentation is a major trigger factor for elevated BP in fragmented sleep and repeated arousals in
patients with periodic leg movements have also been reported to be associated with hypertension.
It is reasonable to think, however, that, in addition to these unfavorable mechanisms, individual
conditions can attenuate or counteract the pressor effects of OSA. This hypothesis is in line with the
results of our meta-analysis. Despite that the majority of the pooled population with OSA exhibited an
ND pattern, a normal circadian BP rhythm was found in a variable, non-marginal fraction of patients
with OSA enrolled by single selected studies.
Some brief additional comments on the clinical features of the studies included in our meta-analysis
may be useful. First, as expected, in the vast majority of the studies, OSA was associated with being
overweight and obese. Second, average night-time systolic and/or diastolic BP values were equal
or higher than 120/70 mmHg in all studies but one that provided this type of information, which
suggests that nocturnal hypertension is a common feature in patients with OSA. Third, severe OSA
was addressed by one specific study, and the prevalence of ND in this cohort was no different from
that reported in other studies including less severe patients, which makes a conclusion on this topic
unfeasible. Lastly, it is useful to underline that the meta-analysis addressing the risk of ND performed
in moderate to severe OSA was based on six studies carried out in individuals with different clinical
characteristics, such as members of the general population, normotensive elderly, and untreated
and/or treated hypertensive patients. This clearly makes it inappropriate to extend our findings to
specific populations.
Limitations of the Study
Five different criteria were used to classify night-time and day-time periods in the studies included
in the present meta-analysis. In addition, different definitions of abnormal nocturnal BP fall (systolic,
systolic-diastolic, or mean BP) were adopted by the authors. These methodological differences in
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defining the ND pattern may have affected our findings. Classification of participants in D and ND,
according to a 10% decrease of night-time BP as defined by a single ABPM recording does not accurately
reflect a sustained BP trait, and its reproducibility over time is limited. Due to the cross-sectional design
of the selected studies, a cause-effect relationship between the OSA and ND patterns remains unproven.
We did not analyze the individual data from the original databases but only the results derived from
revised papers. Mean BMI was significantly higher in subjects with OSA than in controls in three out
of the seven studies included in the meta-analysis [19,26,27]. This could be considered a potential
confounding factor. Moreover, the definition of hypopnea differed between the various studies in terms
of percentage of air-flow reduction, inclusion or not of arousals, and oxygen desaturation. The use
of different criteria in the definition of hypopnea can be a limitation in comparing the results of the
selected studies and, consequently, of their meta-analysis. This also applies to the different methods
of diagnosing OSA (polysomnography vs. polygraphy). Lastly, the restriction to papers published
in English due to problems in interpreting reports in different languages may have partly influenced
our findings.
5. Conclusions
Current evidence on the link between OSA and the ND pattern has been based, so far, on the results
provided by single studies. Our meta-analysis focusing on a large pooled population of patients with
OSA adds further information in this field by showing that the syndrome is associated with a significant
increased risk of abnormal reduction in night-time BP. In a clinical perspective, this observation
supports the view that the ND pattern may be regarded as a marker of OSA, especially when associated
with clinical risk factors for sleep disordered breathing and, conversely, it supports the view that
patients with OSA should be subjected to ABPM in order to identify and treat nocturnal hypertension.
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